HPDL and breast carcinoma: It is important to consider that the PyMT model transcriptionally resembles Luminal B breast cancer, while in human tumours HPDL overexpression is mainly observed in triple negative basal-like breast cancers (S11 Fig), suggesting that the role of tyrosine catabolism might be subtype specific.